HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.

Abstract
Although the identity of T cells involved in the protection against Mycobacterium tuberculosis (Mtb) in humans remain unknown, patients with pulmonary tuberculosis (TB) have reduced numbers of Mtb-reactive, V gamma 9+/V delta 2+ T cells in their blood and lungs. Here we have determined whether this gamma deltaT loss is a consequence of Mtb Ag-mediated activation-induced cell death (AICD). Using a DNA polymerase-mediated dUTP nick translation labeling assay, 5% or less of freshly isolated CD4+ alpha beta or gamma delta T cells from normal healthy individuals and TB patients were apoptotic. However, during culture Mtb Ags induced apoptosis in a large proportion of V gamma 9+V delta 2+ peripheral blood T cells from healthy subjects (30-45%) and TB patients (55-68%); this was increased further in the presence of IL-2. By contrast, anti-CD3 did not induce any significant level of apoptosis in gamma delta T cells from healthy subjects or TB patients. Mtb Ag stimulation rapidly induced Fas and Fas ligand (FasL) expression by gamma delta T cells, and in the presence of metalloproteinase-inhibitors >70% of gamma delta T cells were FasL+. Blockade of Fas-FasL interactions reduced the level of Mtb-mediated gamma delta T cell apoptosis by 75 to 80%. Collectively, these findings demonstrate that Mtb-reactive gamma delta T cells are more susceptible to AICD and that the Fas-FasL pathways of apoptosis is involved. AICD of gamma delta T cells, therefore, provides an explanation for the loss of Mtb-reactive T cells during mycobacterial infection.
AuthorsB Li, H Bassiri, M D Rossman, P Kramer, A F Eyuboglu, M Torres, E Sada, T Imir, S R Carding
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 161 Issue 3 Pg. 1558-67 (Aug 01 1998) ISSN: 0022-1767 [Print] United States
PMID9686624 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Blocking
  • FASLG protein, human
  • Fas Ligand Protein
  • Interleukin-2
  • Ligands
  • Membrane Glycoproteins
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, Antigen, T-Cell, gamma-delta
  • Tumor Necrosis Factor-alpha
  • fas Receptor
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Blocking (pharmacology)
  • Apoptosis (immunology)
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Fas Ligand Protein
  • Female
  • Humans
  • Immunity, Innate
  • Interleukin-2 (physiology)
  • Ligands
  • Lymphocyte Activation
  • Male
  • Membrane Glycoproteins (biosynthesis, immunology, physiology)
  • Middle Aged
  • Mycobacterium tuberculosis (immunology)
  • Receptors, Antigen, T-Cell, alpha-beta (immunology)
  • Receptors, Antigen, T-Cell, gamma-delta (immunology)
  • T-Lymphocyte Subsets (immunology, metabolism, pathology)
  • Tuberculosis, Pulmonary (drug therapy, immunology, pathology)
  • Tumor Necrosis Factor-alpha (physiology)
  • fas Receptor (biosynthesis, immunology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: